This is exactly the sort of weak observational data that I am suspicious of. That same data[1] also shows that the vaccinated are much more likely to get infected, which means either the vaccine actually enhances infectivity, or the two groups are so poorly matched that they can't be compared at all. Either way, the data is weak.
If you look at the matched cohort study I linked, vaccine efficacy against severe outcome isn't anywhere near 90%, but rather 30%-50%. If the vaccine then also fails to protect against infection, as it does with Omikron, it couldn't possibly have 95% efficacy against severe disease. What could explain this discrepancy, other than statistical shenanigans?
If you look at the matched cohort study I linked, vaccine efficacy against severe outcome isn't anywhere near 90%, but rather 30%-50%. If the vaccine then also fails to protect against infection, as it does with Omikron, it couldn't possibly have 95% efficacy against severe disease. What could explain this discrepancy, other than statistical shenanigans?
[1] https://assets.publishing.service.gov.uk/government/uploads/...